GHRH Analog

GHRH analogs are synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic peptide that stimulates pituitary growth hormone (GH) release. These compounds are studied extensively in pituitary signaling research, GH pulsatility studies, and comparative pharmacology of natural versus modified GHRH structures.

Structural modifications in GHRH analogs alter receptor binding affinity, resistance to enzymatic degradation, and half-life — making this family particularly valuable for studying how modifications to a parent peptide influence downstream biological activity. The Drug Affinity Complex (DAC) modification, for example, dramatically extends circulating half-life, allowing researchers to compare pulsatile versus sustained GHRH signaling models.

GHRH analogs in our catalog include CJC-1295 (with and without DAC), Tesamorelin (a stabilized GHRH analog), and pre-mixed GHRH + GHRP combinations for synergistic signaling research.

Each compound is supplied as a lyophilized powder, ≥98% purity, with Certificate of Analysis. For laboratory research use only.